Premium
Decreased viability and absence‐like epilepsy in mice lacking or deficient in the GABA A receptor α1 subunit
Author(s) -
Arain Fazal M.,
Boyd Kelli L.,
Gallagher Martin J.
Publication year - 2012
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1167.2012.03596.x
Subject(s) - haploinsufficiency , epilepsy , juvenile myoclonic epilepsy , protein subunit , electroencephalography , congenic , biology , medicine , endocrinology , viability assay , microbiology and biotechnology , neuroscience , genetics , phenotype , in vitro , gene
Summary Autosomal dominant mutations S326fs328X and A322D in the GABA A receptor α1 subunit are associated with human absence epilepsy and juvenile myoclonic epilepsy, respectively. Because these mutations substantially reduce α1 subunit protein expression in vitro, it was hypothesized that they produce epilepsy by causing α1 subunit haploinsufficiency. However, in a mixed background strain of mice, α1 subunit deletion does not reduce viability or cause visually apparent seizures; the effects of α1 subunit deletion on electroencephalography (EEG) waveforms were not investigated. Here, we determined the effects of α1 subunit loss on viability, EEG spike‐wave discharges and seizures in congenic C57BL/6J and DBA/2J mice. Deletion of α1 subunit caused strain‐ and sex‐dependent reductions in viability. Heterozygous mice experienced EEG discharges and absence‐like seizures within both background strains, and exhibited a sex‐dependent effect on the discharges and viability in the C57BL/6J strain. These findings suggest that α1 subunit haploinsufficiency can produce epilepsy and may be a major mechanism by which the S326fs328X and A322D mutations cause these epilepsy syndromes.